Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib plus Myocet in HER2+ Metastatic Breast Cancer
NCT01495884Phase 2Terminated
- Sponsor
- Cancer Trials Ireland
- Start
- Mar 2011
- Primary completion
- Oct 2014
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib, doxorubicin in breast cancer, sponsored by Cancer Trials Ireland. Started Mar 2011; status: terminated.
02
Drugs
lapatinibdoxorubicin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01495884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01495884.